Uterine benign tumor including myoma is the most common female benign pelvic tumor. Magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU) has been considered to be a minimal invasive treatment. The device used in this trial will be Haifu Focused Ultrasound tumor therapeutic System. In this trial, the investigators will observe the possibility of complication and tumor response of treatment.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
10
The device used in this trial will be Haifu Focused Ultrasound tumor therapeutic System. In Uterine benign tumor female, the investigators will observe the possibility of complication and tumor response of treatment.
National Taiwan University Hospital
Taipei, Taiwan
Evaluation of tumour response
Evaluation of tumour response according to the modified RECIST criteria by sequencing MR imaging
Time frame: 3 month after treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.